AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy
Clinical trial NCT02024308 · UNKNOWN
Trial details
- NCT number
- NCT02024308
- Sponsor
- Changhai Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2015-11-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.